May 20, 2025
12.30 pm – 3.00pm
(including optional Networking Event from 2.00pm to 3.00pm)
In recent years, China’s innovations in the healthcare sector, particularly in medical devices and pharmaceuticals, have grown significantly. With its rapid advancements in innovative medical technology, China is emerging as a key player in addressing global health challenges, particularly in low- and middle-income countries (LMICs).
Many LMICs continue to face structural barriers such as insufficient healthcare infrastructure, limited availability of affordable treatment and diagnostic tools, and a rising burden of non-communicable diseases. In this context, China’s expanding capacity in medical innovation offers an opportunity to explore new pathways toward more sustainable and inclusive healthcare solutions.
This session will convene a diverse group of stakeholders—ranging from representatives of China’s innovative health technology sector to development partners, healthcare professionals, and policymakers—to examine the current landscape of Chinese medical innovations and how they could contribute to addressing health challenges in LMICs. Discussions will focus on the drivers and barriers influencing the adoption of these technologies in developing contexts, and examine the policy frameworks and strategies that can facilitate equitable and effective integration into global health systems.
Founding Dean,
Vanke School of Public Health, Tsinghua University; Emeritus Director General of the World Health Organization
Associate Professor, Vanke School of Public Health, Tsinghua University
Deputy Director, Diagnostics,
Gates Foundation
Senior Program Officer, Gates Foundation
Ministry of Health and Social Welfare, Equatorial Guinea
Deputy Representative, UNFPA China
Senior Health Advisor, Asian Development Bank
Founder & Chief Scientist, Pluslife Biotech
Deputy General Manager, China Sinopharm International Corporation
Founder, Edan Instrument
Tsinghua University Vanke School of Public Health (VSPH)
The Vanke School of Public Health at Tsinghua University, established on April 2, 2020, is a strategic response to global health trends and national health demands. Emphasizing integration, internationalization, and excellence, the School leverages Tsinghua’s multidisciplinary strengths to foster cross-disciplinary collaboration and innovative training models. It focuses on four core areas: public health security, holistic health, health big data, and health policy and management. With a primary focus on graduate education, the School aims to become a leading hub for talent cultivation, interdisciplinary innovation, policy support for “Healthy China,” and a model of global health governance.
To get more information : https://vsph.tsinghua.edu.cn/en/gywm/Overview.htm
Established in 2006 by the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE), the Geneva Health Forum (GHF) is a Swiss not-for-profit initiative that brings together a diverse range of stakeholders to discuss and address global health challenges.
The GHF plays a pivotal role in the global health landscape, as a neutral and inclusive platform, fostering dialogue and collaboration among key players in the field, including policymakers, representatives from academia, civil society, and the private sector.
Its core mission is to facilitate constructive dialogue among these global health actors, which, in turn, contributes to the improvement of health policies and access to care worldwide. The Geneva Health Forum proudly collaborates with some of the most prominent international organizations based in Geneva.